Minaris Regenerative Medicine digitalizes production processes with Werum PAS-X Manufacturing Execution System by Körber

Lüneburg and Ottobrunn, Germany, 13 June 2024. Minaris Regenerative Medicine GmbH (Minaris), a leading contract development and manufacturing organization for cell and gene therapies, has implemented a digital Manufacturing Execution System (MES), the newest version of Werum PAS-X MES by Körber, at its German site in Ottobrunn near Munich. By doing so, Minaris is converting its production management to digital processes and following the right first time principle for highest quality.

With the MES, already parallel to production, batches can be documented paperless, checked and released within the shortest possible time. “Through the ‘review by exception’ concept, we offer our customers efficient processes and more agility in a cost-effective manner”, said Renate Sporrer, COO of Minaris Regenerative Medicine GmbH. 

“We will benefit from operational advantages such as faster batch releases, as well as time and cost savings. Werum PAS-X MES is an important building block for our customers to shorten their time to market.” The status of equipment can also be controlled electronically. In addition, the digital production management system enables Minaris to make a wide range of process information for clients efficiently and quickly available.

Körber's latest version Werum PAS-X MES 3.3 covers all of Minaris’ requirements, which allowed Minaris to implement the software without any customization. By using the “Continuous Evolution Stream” support model, Minaris ensures that the MES system can be updated every six months. The company will regularly benefit from new features as soon as they are released. Via an interface, PAS-X MES integrates the Enterprise Resource Planning (ERP) system into the production IT infrastructure.

Picture
https://www.koerber-pharma.com/en/about-us/press/minaris-regenerative-medicine-digitalizes-production-processes-with-werum-pas-x-manufacturing-execution-system-by-koerber
 
About Körber
We are Körber – an international technology group with more than 12,000 employees at over 100 locations worldwide and a common goal: We turn entrepreneurial thinking into customer success and shape the technological change. In the Business Areas Digital, Pharma, Supply Chain, and Technologies, we offer products, solutions and services that inspire. We act fast to customer needs, we execute ideas seamlessly, and with our innovations we create added value for our customers. In doing so, we are increasingly building on ecosystems that solve the challenges of today and tomorrow. Körber AG is the holding company of the Körber Group.
At the Körber Business Area Pharma we are delivering the difference along the pharma value chain with our unique portfolio of integrated solutions. With our software solutions we help drug manufacturers to digitalize their pharmaceutical, biotech and cell & gene therapy production. The Werum PAS-X MES Suite is recognized as the world’s leading Manufacturing Execution System for pharma, biotech and cell & gene. Our Werum PAS-X Savvy Suite accelerates product commercialization with data analytics and AI solutions and uncovers hidden business value.
www.koerber-pharma.com

Contact
Dirk Ebbecke
Körber Business Area Pharma
Head of Product Marketing
T: +49 4131 8900-0
E-mail: dirk.ebbecke@koerber.com

About Minaris Regenerative Medicine
Minaris Regenerative Medicine is a global contract development and manufacturing organization (CDMO) for cell and gene therapies. We offer our clients high value clinical and commercial manufacturing services, development solutions, and technologies. We are pioneers in the field with more than 20 years’ experience providing outstanding quality and reliability. Our facilities in North America, Europe, and Asia allow us to supply life-changing therapies to patients globally. Minaris Regenerative Medicine is part of the Resonac Group. 
www.rm.minaris.com

Contact
Dr. Almut Windhager
Senior Manager Communications
Minaris Regenerative Medicine GmbH
T: +49 89 700 9608-0
E-mail: press@rm.minaris.de